Manulife Vitality reports future health risk predictors
New research on metabolic health finds that four commonly measured indicators, blood pressure, cholesterol, blood glucose and body mass index, are strongly linked to future health risk, and that structured behavioural support can shift meaningful numbers of people back into healthy ranges, a data point worth weighing carefully rather than citing outright in plan design conversations about prevention.
The report, Within Your Control, draws on a decade of Manulife Vitality member data in Canada to track what happens after people with out-of-range biometric results engage with structured health programming. Among members who began out of range and later completed additional assessments, the report found 53% moved into the healthy range for cholesterol, 46% for blood pressure, 37% for BMI and 23% for blood glucose.
Those figures are worth reading carefully rather than taking at face value. Manulife published different numbers for three of the same overlapping measures just four months earlier: 71% for cholesterol, 47% for blood pressure and 31% for BMI, with no explanation offered for the shift. For advisors and plan sponsors evaluating whether biometric screening and coaching programs deliver measurable results, the inconsistency is a reminder to ask any vendor, not only Manulife, about sample size, measurement window and cohort consistency before treating a single reported percentage as settled evidence.
The underlying research question matters regardless of whose data illustrates it: chronic, largely preventable conditions tied to these same four metabolic markers are a major driver of the gap between how long Canadians live and how many of those additional years are spent in good health. The report frames prevention, not treatment, as the lever most within an individual's control, and structured programming as one route to measurable change in the indicators that predict future risk.
Manulife is using the anniversary to add two resources for Vitality Plus members: Maven's Menopause & Midlife Health program, offering virtual education, coaching and specialist guidance to members and dependants aged 16 and older, and WorldCare's Medical Second Opinion service, connecting members facing serious or complex diagnoses with specialists at teaching and research hospitals for an independent review of their treatment plan.
For benefits advisors, the practical takeaway sits in two places: the four metabolic indicators are a genuinely useful lens for prevention-focused plan design conversations, and the newly added menopause/midlife and second-opinion resources are concrete features worth raising with clients directly, distinct from the outcome statistics, which carry more caveats than the report lets on.
